New Horizons in Nephrology: Glomerular Disease 2022-Reconciling Guidelines with Clinical Practice

LIVECMEConferences & Symposia
New Horizons in Nephrology: Glomerular Disease 2022-Reconciling Guidelines with Clinical Practice Banner

Add to Calendar New Horizons in Nephrology: Glomerular Disease 2022-Reconciling Guidelines with Clinical Practice 9/23/2022 7:50:00 AM 9/23/2022 4:20:00 PM America/New_York Virtual/Smilow Center for Translational Research false MM/DD/YYYY


Date & Location
Friday, September 23, 2022, 7:50 AM - 4:20 PM EST, Virtual/Smilow Center for Translational Research, Philadelphia , PA

Course Overview
Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which are associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases. The recently approved therapies and published guidelines are changing the clinical approach to diagnosis and management. Therefore, it is important for physicians to stay current with these new approaches to managing glomerular diseases.

Target Audience
Specialties - INTERNAL MEDICINE - Nephrology
Professions - Physicians


Objectives

After completing this activity, participants should be able to:


  1. Review the recently published glomerular disease guidelines from the clinical application practice
  2. Identify potential mechanisms responsible for disease progression in FSGS with integration of the genetic testing in clinical practice
  3. Correctly diagnose and effectively treat membranous nephropathy in 2022
  4. Discuss the therapeutic implications of recently approved therapeutics for ANCA vasculitis, IgA nephropathy and lupus nephritis

Registration
REGISTRATION FEES (IN-PERSON ATTENDANCE)
New Horizons in Nephrology: Glomerular Disease 2022: Reconciling Guidelines with Clinical Practice will be held on Friday, September 23, 2022, at the University of Pennsylvania, in the Smilow Center for Translational Research, Rubenstein Auditorium, located in the Perelman Center for Advanced Medicine, 1st floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104
 
The fee to attend in-person is $50 for all attendees. All pre-registered in-person attendees will be able to attend the conference on-site which includes continental breakfast, lunch and breaks. Registration also includes access to view the speaker presentations online for one year. Due to the COVD-19 pandemic, walk-ins are discouraged. Please register no later than September 21 so an accurate count can be made for food and beverages.
 
REGISTRATION FOR LIVE-STREAM (VIRTUAL ATTENDANCE)
Attendees who are registered to attend virtually will receive an email that includes the link to join the conference 48 hours in advance. All virtual attendees will be required to sign into the meeting using your first name, last name, and email address, in order to be marked as attended and receive credit.
 
There is no fee to attend the conference virtually, however, the deadline to register virtually is also September 21, 2022. All pre-registered virtual attendees will receive an email that includes a link with instructions to sign-in and join the virtual conference 48 hours preceding the conference if registration is received prior to September 21, 2022. All registrants will receive conference materials via email 48 hours in advance of the meeting.
 
DIRECTIONS
The Smilow Center for Translational Research, Rubenstein Auditorium, is located in the Perelman Center for Advanced Medicine, 1st floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104.
 
Public Transportation
 
Parking
The 3600 Civic Center Boulevard Parking Garage is advised for non-patient parking. The rate is $20/day. It is a 5-minute walk to the Perelman Center and there is also a shuttle bus. Parking fees will not be validated. Please note the Perelman Center garage is for patients only.
https://www.pennmedicine.org/for-patients-and-visitors/penn-medicine-locations/pavilion/getting-around-the-pavilion/directions-and-parking

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

DESIGNATION OF CREDIT
Physicians: Penn Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 


Credits
AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Attendance / Participation (7.25 hours)